.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
In a significant move within the Indian healthcare sector, the 360 ONE Asset management firm is set to facilitate a major hospital stake buyback. Specifically, they will lend approximately ₹600 crore to Narendra Pandey, the founder of the Asian Institute of Medical Sciences (AIMS). This funding enables the repurchase of a 49% stake currently held by British International Investment and OrbiMed. Consequently, Pandey will consolidate his ownership of the Faridabad-based 450-bed hospital. This transaction highlights the growing reliance on private credit for ownership consolidation in India.
The deal values the hospital at around ₹1,200 crore. Previously, the private equity investors attempted to sell their stakes to other firms. However, those efforts failed due to high valuation expectations. Therefore, Pandey chose to explore structured credit solutions to regain control. This trend is becoming increasingly common among Indian promoters. Furthermore, the healthcare delivery sector remains robust, with standalone hospitals often fetching high valuations based on earnings. As a result, founders are keen to maintain their equity before potentially pursuing public listings.
Consolidation of ownership allows founders to maintain their long-term vision for clinical excellence. In particular, the AIMS founder's decision reflects confidence in the hospital's growth potential. Private credit platforms like 360 ONE now play a pivotal role in such transactions. Additionally, this shift indicates a maturing financial ecosystem for Indian healthcare providers. Moreover, many companies with IPO ambitions prefer this route to streamline their capital structure. Lastly, we are seeing more structured debt deals across various sectors in India.
Q1: Who is financing the AIMS stake buyback?
360 ONE Asset is expected to lend about ₹600 crore to facilitate the transaction for the AIMS founder.
Q2: What is the estimated valuation of AIMS hospital in this deal?
The 450-bed multispecialty hospital is expected to be valued at approximately ₹1,200 crore.
Q3: Why did the previous sale of the stake fail?
Previous attempts to sell the stake to other private equity investors reportedly failed due to high valuation expectations from the sellers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Narendra Pandey, founder of AIMS, is set to repurchase a 49% stake from PE investors with ₹600 crore in funding from 360 ONE Asset management firm....
5 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
